Soleno Therapeutics (SLNO) EBIT Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.20% |
| Dec 31, 2025 | 47.47% |
| Sep 30, 2025 | 36.93% |
| Jun 30, 2025 | 10.23% |
| Mar 31, 2025 | -37.57% |
| Dec 31, 2024 | -54.33% |
| Sep 30, 2024 | -67.23% |
| Jun 30, 2024 | -34.63% |
| Mar 31, 2024 | -36.37% |
| Dec 31, 2023 | -31.52% |
| Sep 30, 2023 | -21.77% |
| Jun 30, 2023 | -20.37% |
| Mar 31, 2023 | -19.50% |
| Dec 31, 2022 | -1.53% |
| Sep 30, 2022 | -18.83% |
| Jun 30, 2022 | -17.96% |
| Mar 31, 2022 | -33.27% |
| Dec 31, 2021 | -10.36% |
| Sep 30, 2021 | -33.31% |
| Jun 30, 2021 | -37.02% |
| Mar 31, 2021 | -16.52% |
| Dec 31, 2020 | -17.81% |
| Sep 30, 2020 | -19.81% |
| Jun 30, 2020 | -29.75% |
| Mar 31, 2020 | -30.78% |
| Dec 31, 2019 | -29.61% |
| Sep 30, 2019 | -35.90% |
| Jun 30, 2019 | -33.89% |
| Mar 31, 2019 | -48.73% |
| Dec 31, 2018 | -44.57% |
| Sep 30, 2018 | -31.32% |